Back

Medscape, LLC

  • Alagille Syndrome

From Uncertainty to Accuracy: Optimizing Outcomes in Adult Genetic Cholestatic Liver Diseases

The goal of this activity is for learners to be better able to identify, diagnose, and treat adult patients with genetic cholestatic liver disease, such as progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS), and appreciate the multisystem aspects of these diseases.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.25 creditsAMA PRA Category 1 Credit™Up to 1.25 creditsNursingUp to 1.25 creditsPharmacyUp to 1.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No
Start Date
November 8, 2026
End Date
December 7, 2026

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Live
  • Credit · Up to 1.25 credits
  • Commercial Support
  • When
    Nov 8 – Dec 6, 2026